Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00399-024-01033-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!